Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11657)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 14, 2014 (publication date) through Jul 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang WB, Yang Y, Zhao YP, Zhang TP, Liao Q, Shu H. Recent studies of 5-fluorouracil resistance in pancreatic cancer. World J Gastroenterol 2014; 20(42): 15682-15690 [PMID: 25400452 DOI: 10.3748/wjg.v20.i42.15682] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i42/15682.htm |
| Number | Citing Articles |
| 1 |
Giordano Perini, Enrico Rosa, Ginevra Friggeri, Lorena Di Pietro, Marta Barba, Ornella Parolini, Gabriele Ciasca, Chiara Moriconi, Massimiliano Papi, Marco De Spirito, Valentina Palmieri. INSIDIA 2.0 High-Throughput Analysis of 3D Cancer Models: Multiparametric Quantification of Graphene Quantum Dots Photothermal Therapy for Glioblastoma and Pancreatic Cancer. International Journal of Molecular Sciences 2022; 23(6): 3217 doi: 10.3390/ijms23063217
|
| 2 |
Yumeng Wei, Panjing Yang, Shousong Cao, Ling Zhao. The combination of curcumin and 5-fluorouracil in cancer therapy. Archives of Pharmacal Research 2018; 41(1): 1 doi: 10.1007/s12272-017-0979-x
|
| 3 |
Myrna Hurtado, Laszlo Prokai, Umesh T. Sankpal, Blair Levesque, Rajasekhar Maram, Jaya Chhabra, Deondra T. Brown, Raj K. Gurung, Alvin A. Holder, Jamboor K. Vishwanatha, Riyaz Basha. Next generation sequencing and functional pathway analysis to understand the mechanism of action of copper-tolfenamic acid against pancreatic cancer cells. Process Biochemistry 2020; 89: 155 doi: 10.1016/j.procbio.2019.10.022
|
| 4 |
Siriwan Sakarin, Nuntana Meesiripan, Suleeporn Sangrajrang, Nuntakan Suwanpidokkul, Piyaporn Prayakprom, Chatchada Bodhibukkana, Vipada Khaowroongrueng, Kankanit Suriyachan, Somchai Thanasittichai, Attasit Srisubat, Pattamaporn Surawongsin, Kasem Rattanapinyopituk. Antitumor Effects of Cannabinoids in Human Pancreatic Ductal Adenocarcinoma Cell Line (Capan-2)-Derived Xenograft Mouse Model. Frontiers in Veterinary Science 2022; 9 doi: 10.3389/fvets.2022.867575
|
| 5 |
Farhad Sheikhnia, Hossein Maghsoudi, Maryam Majidinia. The Critical Function of microRNAs in Developing Resistance against 5-
Fluorouracil in Cancer Cells. Mini-Reviews in Medicinal Chemistry 2024; 24(6): 601 doi: 10.2174/1389557523666230825144150
|
| 6 |
Shamin Azwar, Heng Fong Seow, Maha Abdullah, Mohd Faisal Jabar, Norhafizah Mohtarrudin. Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment. Biology 2021; 10(9): 854 doi: 10.3390/biology10090854
|
| 7 |
Zhengjun Lin, Shiyao Lu, Xubin Xie, Xuyang Yi, He Huang. Noncoding RNAs in drug-resistant pancreatic cancer: A review. Biomedicine & Pharmacotherapy 2020; 131: 110768 doi: 10.1016/j.biopha.2020.110768
|
| 8 |
Dhanya Moorkoth, Kesavan Madhavan Nampoothiri, Selvaraj Nagarajan, Aswathy Ravindran Girija, Sivakumar Balasubramaniyan, D. Sakthi Kumar. Star-Shaped Polylactide Dipyridamole Conjugated to 5-Fluorouracil and 4-Piperidinopiperidine Nanocarriers for Bioimaging and Dual Drug Delivery in Cancer Cells. ACS Applied Polymer Materials 2021; 3(2): 737 doi: 10.1021/acsapm.0c01043
|
| 9 |
Jebraeel Movaffagh, Hamide Salari, Elahe Merajifar, Hamid Gholam hosseinian, Azadeh Shahroodi, Mehrdad Iranshahi, Fatemeh B. Rassouli. 7-geranyloxycoumarin enhanced radiotherapy effects on human gastric adenocarcinoma cells. Journal of Cancer Research and Therapeutics 2023; 19(3): 590 doi: 10.4103/jcrt.jcrt_701_21
|
| 10 |
Matthew B. Lipner, Xianlu L. Peng, Chong Jin, Yi Xu, Yanzhe Gao, Michael P. East, Naim U. Rashid, Richard A. Moffitt, Silvia G. Herrera Loeza, Ashley B. Morrison, Brian T. Golitz, Cyrus Vaziri, Lee M. Graves, Gary L. Johnson, Jen Jen Yeh. Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy. JCI Insight 2020; 5(8) doi: 10.1172/jci.insight.129905
|
| 11 |
Klaudia Siwowska, Raffaella Schmid, Susan Cohrs, Roger Schibli, Cristina Müller. Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization. Pharmaceuticals 2017; 10(3): 72 doi: 10.3390/ph10030072
|
| 12 |
Lukas M. Braun, Simon Lagies, Jessica Guenzle, Stefan Fichtner-Feigl, Uwe A. Wittel, Bernd Kammerer. Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines. Cells 2020; 9(5): 1251 doi: 10.3390/cells9051251
|
| 13 |
Nkafu Bechem Ndemazie, Andriana Inkoom, Dexter Ebesoh, Raviteja Bulusu, Esther Frimpong, Jose Trevino, Bo Han, Xue Zhu, Edward Agyare. Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10449-y
|
| 14 |
Esther Frimpong, Raviteja Bulusu, Joy Okoro, Andriana Inkoom, Nkafu Ndemazie, Sherise Rogers, Xue Zhu, Bo Han, Edward Agyare. Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer. European Journal of Pharmaceutical Sciences 2024; 196: 106754 doi: 10.1016/j.ejps.2024.106754
|
| 15 |
Thangirala Sudha, Kavitha Godugu, Gennadi V. Glinsky, Shaker A. Mousa. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022; 10(4): 795 doi: 10.3390/biomedicines10040795
|
| 16 |
Lucas D. Lee, Ioannis Pozios, Verena Liu, Silke B. Nachbichler, Dirk Böhmer, Carsten Kamphues, Katharina Beyer, Christiane J. Bruns, Martin E. Kreis, Hendrik Seeliger. Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreatic adenocarcinoma. Radiation and Environmental Biophysics 2022; 61(2): 255 doi: 10.1007/s00411-022-00962-w
|
| 17 |
Zhaorong Chen, Aling Shen, Liya Liu, Youqin Chen, Jianfeng Chu, Qiaoyan Cai, Fei Qi, Thomas Joseph Sferra, Jun Peng. Pien Tze Huang induces apoptosis and inhibits proliferation of 5-fluorouracil-resistant colorectal carcinoma cells via increasing miR-22 expression. Experimental and Therapeutic Medicine 2017; 14(4): 3533 doi: 10.3892/etm.2017.4951
|
| 18 |
Sanaz Naghizadeh, Behzad Mansoori, Ali Mohammadi, Ebrahim Sakhinia , Behzad Baradaran. Gene Silencing Strategies in Cancer Therapy: An Update for Drug Resistance. Current Medicinal Chemistry 2019; 26(34): 6282 doi: 10.2174/0929867325666180403141554
|
| 19 |
Patricia Santofimia-Castaño, Juan Iovanna. Combating pancreatic cancer chemoresistance by triggering multiple cell death pathways. Pancreatology 2021; 21(3): 522 doi: 10.1016/j.pan.2021.01.010
|
| 20 |
Girijesh Kumar Patel, Mohammad Aslam Khan, Arun Bhardwaj, Sanjeev K Srivastava, Haseeb Zubair, Mary C Patton, Seema Singh, Moh'd Khushman, Ajay P Singh. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK. British Journal of Cancer 2017; 116(5): 609 doi: 10.1038/bjc.2017.18
|
| 21 |
Eun-Kyung Kim, MinGyeong Jang, Min-Jeong Song, Dongwoo Kim, Yosup Kim, Ho Hee Jang. Redox-Mediated Mechanism of Chemoresistance in Cancer Cells. Antioxidants 2019; 8(10): 471 doi: 10.3390/antiox8100471
|
| 22 |
Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti. Drug resistance in pancreatic cancer: Impact of altered energy metabolism. Critical Reviews in Oncology/Hematology 2017; 114: 139 doi: 10.1016/j.critrevonc.2017.03.026
|
| 23 |
Elisa Majounie, Kathleen Wee, Laura M. Williamson, Martin R. Jones, Erin Pleasance, Howard J. Lim, Cheryl Ho, Daniel J. Renouf, Stephen Yip, Steven J.M. Jones, Marco A. Marra, Janessa Laskin. Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant. Molecular Case Studies 2020; 6(1): a004713 doi: 10.1101/mcs.a004713
|
| 24 |
Huaichuan Duan, Kaixuan Hu, Dan Zheng, Yan Cheng, Zelan Zhang, Yueteng Wang, Li Liang, Jianping Hu, Ting Luo. Recognition and release of uridine and hCNT3: From multivariate interactions to molecular design. International Journal of Biological Macromolecules 2022; 223: 1562 doi: 10.1016/j.ijbiomac.2022.11.145
|
| 25 |
Imlimaong Aier, Rahul Semwal, Aiindrila Dhara, Nirmalya Sen, Pritish Kumar Varadwaj, James Freeman. An integrated epigenome and transcriptome analysis identifies PAX2 as a master regulator of drug resistance in high grade pancreatic ductal adenocarcinoma. PLOS ONE 2019; 14(10): e0223554 doi: 10.1371/journal.pone.0223554
|
| 26 |
Ali Alsuraifi, Paul Kong Thoo Lin, Anthony Curtis, Dimitrios A. Lamprou, Clare Hoskins. A Novel PAA Derivative with Enhanced Drug Efficacy in Pancreatic Cancer Cell Lines. Pharmaceuticals 2018; 11(4): 91 doi: 10.3390/ph11040091
|
| 27 |
Vadim V. Tarasov, Vladimir N. Chubarev, Ghulam Md Ashraf, Samira A. Dostdar, Alexander V. Sokolov, Tatiana I. Melnikova, Susanna S. Sologova, Ekaterina M. Grigorevskich, Alfiya Makhmutovа, Alexander S. Kinzirsky, Sergey G. Klochkov, Gjumrakch Aliev. How Cancer Cells Resist Chemotherapy: Design and Development of Drugs Targeting Protein-Protein Interactions. Current Topics in Medicinal Chemistry 2019; 19(6): 394 doi: 10.2174/1568026619666190305130141
|
| 28 |
Xinru Yue, Xun Zhang, Derong Zhang, Zhigang Zhang, Lingkai Tang, Zuoxin Ou, Yujie Cao, Jing Li, Ying Li, Li Liang, Wei Liu, Jianping Hu. Research Progress on hCNT3 Structure/Function and Nucleoside Anticancer
Drugs. Current Protein & Peptide Science 2024; 25(2): 120 doi: 10.2174/1389203724666230905110952
|
| 29 |
Md Jalal Uddin, Hermen S. Overkleeft, Christian S. Lentz. Activity‐Based Protein Profiling in Methicillin‐Resistant Staphylococcus aureus Reveals the Broad Reactivity of a Carmofur‐Derived Probe. ChemBioChem 2023; 24(21) doi: 10.1002/cbic.202300473
|
| 30 |
Mounira Chalabi-Dchar, Tanguy Fenouil, Christelle Machon, Anne Vincent, Frédéric Catez, Virginie Marcel, Hichem C Mertani, Jean-Christophe Saurin, Philippe Bouvet, Jérôme Guitton, Nicole Dalla Venezia, Jean-Jacques Diaz. A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fate. NAR Cancer 2021; 3(3) doi: 10.1093/narcan/zcab032
|
| 31 |
Btissame El Hassouni, Giovanna Li Petri, Daniel S.K. Liu, Stella Cascioferro, Barbara Parrino, Waqar Hassan, Patrizia Diana, Asif Ali, Adam E Frampton, Elisa Giovannetti. Pharmacogenetics of treatments for pancreatic cancer. Expert Opinion on Drug Metabolism & Toxicology 2019; 15(6): 437 doi: 10.1080/17425255.2019.1620731
|
| 32 |
Gonçalo Mesquita, Aurélien Haustrate, Adriana Mihalache, Benjamin Soret, Clément Cordier, Emilie Desruelles, Erika Duval, Zoltan Pethö, Natalia Prevarskaya, Albrecht Schwab, V’yacheslav Lehen’kyi. TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics. Cancers 2023; 15(24): 5769 doi: 10.3390/cancers15245769
|
| 33 |
Nestor Prieto-Dominguez, Austin Y Shull, Yong Teng. Making Way for Suppressing the FGF19/FGFR4 Axis in Cancer. Future Medicinal Chemistry 2018; 10(20): 2457 doi: 10.4155/fmc-2018-0099
|
| 34 |
Adriana Harbuzariu, Ruben Rene Gonzalez-Perez. Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer. Oncotarget 2018; 9(26): 18239 doi: 10.18632/oncotarget.24435
|
| 35 |
Takashi Hoshiba, Masaru Tanaka. Decellularized matrices as in vitro models of extracellular matrix in tumor tissues at different malignant levels: Mechanism of 5-fluorouracil resistance in colorectal tumor cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2016; 1863(11): 2749 doi: 10.1016/j.bbamcr.2016.08.009
|
| 36 |
Chiara Caparello, Laura L Meijer, Ingrid Garajova, Alfredo Falcone, Tessa Y Le Large, Niccola Funel, Geert Kazemier, Godefridus J Peters, Enrico Vasile, Elisa Giovannetti. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer. World Journal of Gastroenterology 2016; 22(31): 6987-7005 doi: 10.3748/wjg.v22.i31.6987
|
| 37 |
Oscar Briz, Laura Perez-Silva, Ruba Al-Abdulla, Lorena Abete, Maria Reviejo, Marta R. Romero, Jose J.G. Marin. What “The Cancer Genome Atlas” database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs. Expert Opinion on Drug Metabolism & Toxicology 2019; 15(7): 577 doi: 10.1080/17425255.2019.1631285
|
| 38 |
Ding Wang, Dan Yu, Xueshibojie Liu, Qian Wang, Xuyang Chen, Xindan Hu, Qiong Wang, Chunshun Jin, Lianji Wen, Ling Zhang. Targeting laryngeal cancer cells with 5-fluorouracil and curcumin using mesoporous silica nanoparticles. Technology in Cancer Research & Treatment 2020; 19: 153303382096211 doi: 10.1177/1533033820962114
|
| 39 |
Abdullah A. Ghawanmeh, Kwok Feng Chong, Shaheen M. Sarkar, Muntaz Abu Bakar, Rizafizah Othaman, Rozida M. Khalid. Colchicine prodrugs and codrugs: Chemistry and bioactivities. European Journal of Medicinal Chemistry 2018; 144: 229 doi: 10.1016/j.ejmech.2017.12.029
|
| 40 |
Suresh Chava, Meher B. Gayatri, Aramati B.M. Reddy. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. 2019; : 25 doi: 10.1016/B978-0-12-817661-0.00003-2
|
| 41 |
Niklas Sturm, Thomas J. Ettrich, Lukas Perkhofer. The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy. Cancers 2022; 14(1): 217 doi: 10.3390/cancers14010217
|
| 42 |
Jose J. G. Marin, Candela Cives-Losada, Maitane Asensio, Elisa Lozano, Oscar Briz, Rocio I. R. Macias. Mechanisms of Anticancer Drug Resistance in Hepatoblastoma. Cancers 2019; 11(3): 407 doi: 10.3390/cancers11030407
|
| 43 |
Angelika Długosz-Pokorska, Joanna Drogosz, Marlena Pięta, Tomasz Janecki, Urszula Krajewska, Marek Mirowski, Anna Janecka. New Uracil Analogs with Exocyclic Methylidene Group as Potential Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry 2020; 20(3): 359 doi: 10.2174/1871520619666191211104128
|
| 44 |
Masaaki Murakawa, Toru Aoyama, Yohei Miyagi, Yosuke Atsumi, Keisuke Kazama, Koichiro Yamaoku, Amane Kanazawa, Manabu Shiozawa, Satoshi Kobayashi, Makoto Ueno, Manabu Morimoto, Naoto Yamamoto, Takashi Oshima, Takaki Yoshikawa, Yasushi Rino, Munetaka Masuda, Soichiro Morinaga. Clinical implications of dihydropyrimidine dehydrogenase expression in patients with pancreatic cancer who undergo curative resection with S-1 adjuvant chemotherapy. Oncology Letters 2017; 14(2): 1505 doi: 10.3892/ol.2017.6295
|
| 45 |
Welley S. Loc, Samuel S. Linton, Zachary R. Wilczynski, Gail L. Matters, Christopher O. McGovern, Thomas Abraham, Todd Fox, Christopher M. Gigliotti, Xiaomeng Tang, Amra Tabakovic, Jo Ann Martin, Gary A. Clawson, Jill P. Smith, Peter J. Butler, Mark Kester, James H. Adair. Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer. Nanomedicine: Nanotechnology, Biology and Medicine 2017; 13(7): 2313 doi: 10.1016/j.nano.2017.06.017
|
| 46 |
Dafydd A. Dart, Damla E Arisan, Sioned Owen, Chunyi Hao, Wen G. Jiang, Pinar Uysal-Onganer. Wnt-11 Expression Promotes Invasiveness and Correlates with Survival in Human Pancreatic Ductal Adeno Carcinoma. Genes 2019; 10(11): 921 doi: 10.3390/genes10110921
|
| 47 |
Yibo Fu, Francesca Ricciardiello, Gang Yang, Jiangdong Qiu, Hua Huang, Jianchun Xiao, Zhe Cao, Fangyu Zhao, Yueze Liu, Wenhao Luo, Guangyu Chen, Lei You, Ferdinando Chiaradonna, Lianfang Zheng, Taiping Zhang. The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells. Cells 2021; 10(3): 497 doi: 10.3390/cells10030497
|
| 48 |
Sugata Barui, Nicolò Maria Percivalle, Marzia Conte, Bianca Dumontel, Luisa Racca, Marco Carofiglio, Valentina Cauda. Development of doped ZnO-based biomimicking and tumor-targeted nanotheranostics to improve pancreatic cancer treatment. Cancer Nanotechnology 2022; 13(1) doi: 10.1186/s12645-022-00140-z
|
| 49 |
Yuan Tian, Wenwen Han, Long Fu, Kaiji Lv, Xinhua Zhou. Silencing of IGHG1 reverses the resistance of pancreatic cancer to multidrug chemotherapy by modulating autophagy. Environmental Toxicology 2023; 38(8): 1835 doi: 10.1002/tox.23810
|
| 50 |
Chinmayee Sethy, Chanakya Nath Kundu. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. Biomedicine & Pharmacotherapy 2021; 137: 111285 doi: 10.1016/j.biopha.2021.111285
|
| 51 |
Liu Ouyang, Min-min Sun, Ping-sheng Zhou, Yi-wei Ren, Xin-yu Liu, Wan-ying Wei, Zhen-shun Song, Kai Lu, Li-xue Yang. LncRNA FOXD1-AS1 regulates pancreatic cancer stem cell properties and 5-FU resistance by regulating the miR-570-3p/SPP1 axis as a ceRNA. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-023-03181-5
|
| 52 |
Mateusz Kciuk, Martyna Malinowska, Adrianna Gielecińska, Rajamanikandan Sundaraj, Somdutt Mujwar, Anna Zawisza, Renata Kontek. Synthesis, Computational, and Anticancer In Vitro Investigations of Aminobenzylnaphthols Derived from 2-Naphtol, Benzaldehydes, and α-Aminoacids via the Betti Reaction. Molecules 2023; 28(20): 7230 doi: 10.3390/molecules28207230
|
| 53 |
Myrna Hurtado, Umesh T. Sankpal, Amalendu Ranjan, Rajasekhar Maram, Jamboor K. Vishwanatha, Ganji Purnachandra Nagaraju, Bassel F. El-Rayes, Riyaz Basha. Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer. Critical Reviews in Oncology/Hematology 2018; 126: 201 doi: 10.1016/j.critrevonc.2018.03.016
|
| 54 |
Yitian Chen, Liangping Su, Cheng Huang, Sangqing Wu, Xiaoyi Qiu, Xinbao Zhao, Qiong Meng, Ya-Ming Meng, Xiangzhan Kong, Minghui Wang, Chao Liu, Ping-Pui Wong. Galactosyltransferase B4GALT1 confers chemoresistance in pancreatic ductal adenocarcinomas by upregulating N-linked glycosylation of CDK11p110. Cancer Letters 2021; 500: 228 doi: 10.1016/j.canlet.2020.12.006
|
| 55 |
Mohini Singh, Paulami Pal, Rajat Subhra Dutta, Daphisha Marbaniang, Subhabrata Ray, Bhaskar Mazumder. Nanodiamond Mediated Molecular Targeting in Pancreatic Ductal Adenocarcinoma:
Disrupting the Tumor-stromal Cross-talk, Next Hope on the
Horizon?. Current Cancer Drug Targets 2023; 23(8): 620 doi: 10.2174/1568009623666230227120837
|
| 56 |
Ibtehal Mohammed, Ali Haider Alhammer, Inam Sameh Arif. The p53 reactivator PRIMA-1MET synergises with 5-fluorouracil to induce apoptosis in pancreatic cancer cells. Investigational New Drugs 2023; 41(4): 587 doi: 10.1007/s10637-023-01380-5
|
| 57 |
Mi-Ju Kim, Min-Sun Kim, Sung Joo Kim, Soyeon An, Jin Park, Hosub Park, Jae Hoon Lee, Ki-Byung Song, Dae Wook Hwang, Suhwan Chang, Kyu-pyo Kim, Seong-Yun Jeong, Song Cheol Kim, Seung-Mo Hong. Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients. Cancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0416-8
|
| 58 |
Isabel Mejia, Sandhya Bodapati, Kathryn T. Chen, Begoña Díaz. Pancreatic Adenocarcinoma Invasiveness and the Tumor Microenvironment: From Biology to Clinical Trials. Biomedicines 2020; 8(10): 401 doi: 10.3390/biomedicines8100401
|
| 59 |
Marzia Conte, Valentina Cauda. Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments. Advanced Therapeutics 2022; 5(11) doi: 10.1002/adtp.202200079
|
| 60 |
Yoonseon Jeong, Joo Weon Lim, Hyeyoung Kim. Lycopene Inhibits Reactive Oxygen Species-Mediated NF-κB Signaling and Induces Apoptosis in Pancreatic Cancer Cells. Nutrients 2019; 11(4): 762 doi: 10.3390/nu11040762
|
| 61 |
JUNRO KATAOKA, HIDENORI SHIRAHA, SHIGERU HORIGUCHI, HIROAKI SAWAHARA, DAISUKE UCHIDA, TERUYA NAGAHARA, MASAYA IWAMURO, HIROKI MORIMOTO, YASUTO TAKEUCHI, KENJI KUWAKI, HIDEKI ONISHI, SHINICHIRO NAKAMURA, AKINOBU TAKAKI, KAZUHIRO NOUSO, TAKAHITO YAGI, KAZUHIDE YAMAMOTO, HIROYUKI OKADA. Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma. Oncology Reports 2016; 35(5): 2576 doi: 10.3892/or.2016.4681
|
| 62 |
Samaneh Pasban, Heidar Raissi, Majid Pakdel, Farzaneh Farzad. Enhance the efficiency of 5-fluorouracil targeted delivery by using a prodrug approach as a novel strategy for prolonged circulation time and improved permeation. International Journal of Pharmaceutics 2019; 568: 118491 doi: 10.1016/j.ijpharm.2019.118491
|
| 63 |
Woonghee Lee, Gwonhwa Song, Hyocheol Bae. Laminarin Attenuates ROS-Mediated Cell Migration and Invasiveness through Mitochondrial Dysfunction in Pancreatic Cancer Cells. Antioxidants 2022; 11(9): 1714 doi: 10.3390/antiox11091714
|
| 64 |
Lihong Shen, Junping Hu, Haixian Wang, Aibing Wang, Yisheng Lai, Yanhui Kang. Synthesis and biological evaluation of novel uracil and 5-fluorouracil-1-yl acetic acid-colchicine conjugate. Chemical Research in Chinese Universities 2015; 31(3): 367 doi: 10.1007/s40242-015-4445-3
|
| 65 |
Thu Phuong Nguyen, Sławomir Wilczewski, Jakub Lewandowski, Agnieszka Majkowska-Pilip, Kinga Żelechowska-Matysiak, Dorota Nieciecka, Waldemar Studziński, Sunday Joseph Olusegun, Marcin Syczewski, Michael Giersig, Thi Mai Thanh Dinh, Paweł Krysiński, Magdalena Osial. 5-fluorouracil and curcuminoids extract from Curcuma longa L. loaded into nanohydroxyapatite as a drug delivery carrier for SKOV-3 and HepG2 cancer cells treatment. Ceramics International 2023; 49(15): 25775 doi: 10.1016/j.ceramint.2023.05.123
|
| 66 |
Saffiyeh Saboor-Maleki, Fatemeh B. Rassouli, Maryam M. Matin, Mehrdad Iranshahi. Auraptene Attenuates Malignant Properties of Esophageal Stem-Like Cancer Cells. Technology in Cancer Research & Treatment 2017; 16(4): 519 doi: 10.1177/1533034616650119
|
| 67 |
Alexey Dementiev, Andrzej Joachimiak, Ha Nguyen, Alexei Gorelik, Katalin Illes, Saman Shabani, Michael Gelsomino, Eun-Young Erin Ahn, Bhushan Nagar, Ninh Doan. Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur. Journal of Medicinal Chemistry 2019; 62(2): 987 doi: 10.1021/acs.jmedchem.8b01723
|
| 68 |
Wenyue Liu, Jingwei Zhang, Xuequan Yao, Chao Jiang, Ping Ni, Lingge Cheng, Jiali Liu, Suiying Ni, Qianying Chen, Qingran Li, Kai Zhou, Guangji Wang, Fang Zhou. Bevacizumab‐enhanced antitumor effect of 5‐fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2‐specificity protein 1 pathway. Cancer Science 2018; 109(10): 3294 doi: 10.1111/cas.13779
|
| 69 |
Yoshihiko Tasaki, Miho Suzuki, Keisuke Katsushima, Keiko Shinjo, Kenta Iijima, Yoshiteru Murofushi, Aya Naiki-Ito, Kazuki Hayashi, Chenjie Qiu, Akiko Takahashi, Yoko Tanaka, Tokuichi Kawaguchi, Minoru Sugawara, Tomoya Kataoka, Mitsuru Naito, Kanjiro Miyata, Kazunori Kataoka, Tetsuo Noda, Wentao Gao, Hiromi Kataoka, Satoru Takahashi, Kazunori Kimura, Yutaka Kondo. Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer. Cancer Research 2021; 81(7): 1654 doi: 10.1158/0008-5472.CAN-20-3021
|